The ubiquitin interaction motif (UIM)-containing protein RAP80 was recently found to play a key role in DNA damage response (DDR) signaling by facilitating the translocation of several DDR mediators, including BRCA1, to ionizing irradiation (IR)-induced foci (IRIF). In this study, we examine the effect of the loss of RAP80 on genomic stability and the susceptibility to cancer development in RAP80 null (RAP80 -/-) mice. RAP80 -/-mice are viable and did not exhibit any apparent developmental defects. Mouse embryonic fibroblasts (MEFs) derived from RAP80
Introduction
A proper response to DNA damage is essential for maintaining genomic stability and to prevent the accumulation and transmission of damaged DNA during cell division (1) . Among the different types of DNA damage, DNA double-strand breaks (DSBs) are the most detrimental to mammalian cells. DSBs activate a DNA damage response (DDR) that coordinates the activation of cell cycle checkpoints, apoptosis, and DNA repair networks, to ensure accurate repair and genomic integrity. Defects in DNA repair mechanisms are associated with various human developmental and immune disorders and an increased cancer risk (2) (3) (4) (5) .
The DDR is initiated by sensors, such as the Mre11-Rad50-Nbs1 (MRN) complex, that detect DSBs and recruit effectors that carry out the repair, and mediators that promote the interactions between effectors and sensors (1, (6) (7) (8) (9) . At an early stage, the MRN recruits the ATM kinase, which upon activation catalyzes the phosphorylation of many proteins, including the histone variant H2AX (ȖH2AX), and promotes the recruitment and phosphorylation of MDC1 (1, (6) (7) (8) 10) . Interaction of MDC1 with RING-finger ubiquitin ligase RNF8 and the subsequent association with the E2 ubiquitin-conjugating enzyme Ubc13 leads to the K63-or K6-linked polyubiquitylation of histones H2AX and H2A at the chromatin flanking DSBs, thereby amplifying the DSBs signals. The accumulation of DDR protein complexes at the break sites results in the formation of distinctive nuclear foci (ionizing radiation (IR)-induced foci or IRIF) (11, 12) .
translocation is mediated at least in part by the interaction of the UIMs of RAP80 to K63-linked polyubiquitin chains in histones at or near DSBs (11, 12) . Cells in which RAP80 is knockeddown by siRNA, are impaired in forming and retaining IRIF containing BRCA1 and other downstream DDR proteins. These cells also exhibit increased radiosensitivity and impaired cell cycle checkpoints. In addition to its link with BRCA1, RAP80 was shown to be directly regulated by p53 and found to be associated with p53 in complex with E3 ubiquitin ligase HDM2 protein (18) .
Its role in DDR and the potential link between RAP80 mutations and human mammary and ovarian cancer, suggested that defective RAP80 function/expression might result in genomic instability and increased cancer risk (5, 21) . In this study, we investigated the effect of the loss of RAP80 expression on genomic stability and cancer development in RAP80 -/-mice using several tumorigenesis models, including IR-induced lymphoma and 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary cancer. Our results demonstrated that RAP80 protects against genomic instability and reduces cancer risk supporting the hypothesis that RAP80 functions as a tumor suppressor.
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Material and Methods

Generation of RAP80 null Mice
RAP80
fx/fx (B6(C)-Uimc tm1.1Amj
) and RAP80 null mice (B6(C)-Uimc1 tm1.1Amj
, referred to as RAP80 -/-) were generated as described in Supplemental Information and Fig. 1A and B.
Tumorigenesis studies
The formation of spontaneous tumors was monitored in male and female WT and RAP80 
In vitro MEF proliferation assays
RAP80
-/-and WT MEFs were generated according to standard procedures (23 doubling time (Td) can be calculated with the following formula, Td = (t 2 -t 1 ) * log (2 -q 2 /q 1 ). To measure actively proliferating cells, MEFs at various passages were pulse-labeled with 10 mM BrdU. After fixation cells were incubated with a biotinylated anti-BrdU antibody, and subsequently with a streptavidin-horseradish peroxidase-coupled secondary antibody and diaminobenzidine. Cells were counterstained with Harris hematoxylin (blue staining).
Immortalized MEFs (iMEFs) were generated by SV40 T-antigen viral expression as described (24) .
Immunofluorescence
Passage 3 MEFs or iMEFs derived from WT and RAP80
-/-littermates were seeded onto coverslips and either left untreated or subjected to 4 or 10 Gy of Ȗ radiation. At various time points after IR, the MEFs were fixed with 4% paraformaldehyde, permeabilized in 0.2% Triton X-100, and blocked in Superblock blocking buffer (Piece), followed by staining with rabbit anti- Colony-forming assay and β-galactosidase staining iMEFs were seeded on 60-mm culture dishes (3 × 10 3 cells/dish). Cultures were either left untreated or subjected to various doses of Ȗ radiation or UV and incubated for 14 days at 37°C.
Cells were then stained with 1% Coomassie brilliant blue, 5% acetic acid, and 30% methanol and the number of colonies was counted. Senescence-associated (SA-β-gal) staining of MEFs was performed according to the manufacturer's protocol (BioVision).
Cell cycle analysis
MEFs or iMEFs were either left untreated or treated with various doses of Ȗ radiation. At 24 h or 48h after radiation, cells were lifted by trypsin treatment and fixed in ice cold 70% ethanol before store in -20 o C for overnight. Cells were then washed once with ice cold PBS and stained with PI for 30 min before subject to Facsort to determine the DNA content. Cell cycle percentages were analyzed using Modfit software (Verity).
Sensitivity to IR and chemical stressors
MEFs, iMEFs or thymocytes (0.5-1 × 10 6 /ml in RPMI medium supplemented with 10% FCS and 5 × 10 í5 M β-mercaptoethanol) were either left untreated or subjected to Ȗ or UV radiation, or treated with doxorubicin, 5-fluorouracil, or nutlin-3a (Sigma) at the doses indicated (18) . After
Results
Generation and characterization of RAP80-null mice
To obtain greater insights into the physiological functions of RAP80, we generated RAP80-null mice by crossing RAP80 fx/fx mice with Tg(CMV-Cre) mice as described in Supplemental Information and Fig. 1A and B. QRT-PCR showed that RAP80 mRNA expression was undetectable in testis, spleen and thymus, which normally express high levels of RAP80 (Fig.   1C ). Western blot and immunofluorescence analysis showed that after IR treatment phosphorylated RAP80 was undetectable and did not accumulate at IRIFs in RAP80 -/-MEFs consistent with the absence of RAP80 protein in these cells ( Fig. 1D and E).
RAP80
-/-mice exhibited a normal appearance and no anatomical or developmental defects were apparent. Deficiency in several DDR genes have been reported to affect spermatogenesis and to cause a reduction in the number of lymphocytes (26, 27) ; however, spermatogenesis appeared normal (data not shown) and both male and female RAP80 -/-mice were fertile. FACS analysis showed little change in different CD4/CD8 thymocyte subpopulations between RAP80
-/-and WT mice suggesting that loss of RAP80 did not affect thymopoiesis in a major way (data not shown).
Effect of RAP80 deficiency on senescence and radiosensitivity
The doubling time of RAP80 -/-MEFs increased more rapidly upon passing than that of WT MEFs ( Fig. 2A ) and contained a lower number of bromodeoxyuridine (BrdU)-positive cells ( Ku70, and ATM (28, 29) . Immortalized RAP80 -/-and WT iMEFs no longer showed significant differences in proliferation and did not contain senescent cells (not shown). However, after UV irradiation, RAP80 -/-iMEF cultures contained a larger number of senescent-like cells than those of WT iMEFs (Fig. S1B ).
Because of its role in DDR, we examined whether the loss of RAP80 had any effect on radiosensitivity by examining the effect of IR on colony forming efficiency (CFE). Although at 2 and 4 Gy, IR reduced the CFE of RAP80 -/-iMEFs to a greater extent than WT iMEFs, the differences were not statistically significant; however, at 6 Gy the reduction in CFE was significantly greater in RAP80 -/-than WT iMEFs (Fig. 2C ). Consistent with these observations, examination of the effect of IR on isolated thymocytes showed that RAP80 -/-thymocytes were significantly more sensitive to IR-induced cell death than WT thymocytes (Fig. 2D ). RAP80
-/-mice exhibited a slightly greater susceptibility to whole body IR compared to WT littermates (Fig. S2) ; however, the difference was not statistically significant.
Effect of the loss of RAP80 on BRCA1 IRIF
Previous studies indicated that RAP80 facilitated the translocation of BRCA1 to IRIF (14) (15) (16) (17) .
To further evaluate the effect of the loss of RAP80 on the localization of BRCA1 to IRIF, we compared the dynamics of BRCA1 foci formation in response to IR in WT or RAP80 -/-MEFs.
Although the loss of RAP80 did not prevent the formation of BRCA1 IRIF, a significant decrease in foci intensity and the percentage of cells containing nuclei with > 5 BRCA1 + foci was observed in RAP80 -/-MEFs compared to WT MEFs 8 h after IR (Fig. 3A, B ). This observation is consistent with a recent study showing that knockdown of RAP80 expression by
Research. siRNAs in U2OS cells did not prevent the formation of BRCA1 IRIF, but diminished the intensity of the foci and particularly reduced the retention of the foci at later time points (30) .
Increased sensitivity of RAP80
-/-MEFs to DNA damage agents and enhanced activation of
p53-dependent pro-apoptotic pathways
Previously, we demonstrated that siRNA knockdown of RAP80 expression stabilizes p53 and results in increased transactivation of p53 target genes and increased apoptosis following DNA damage (18) . We therefore determined whether RAP80 -/-MEFs responded in a similar manner.
Except for nutlin, which activates p53 by inhibiting its interaction with mdm2 without causing DNA damage, all treatments resulted in significantly more cell death in RAP80 -/-MEFs than in WT MEFs (Fig. 4A) . However, this difference in cell death was greatly reduced in WT and RAP80 -/-iMEFs, which might be related to the inactivation of p53 by SV40 T-antigen (Fig. 4B) .
Moreover, IR, UV, doxorubicin and fluorouracil all increased the induction of the p53 target genes, Bax, Siva1 and Puma, to a greater extent in RAP80 -/-MEFs than in WT MEFs, while the induction of these genes by nutlin was not significantly different between RAP80 -/-and WT MEFs (Fig. 4C, Fig. S3 ). Little difference was observed in p21 expression.
Loss of RAP80 leads to prolonged G2/M cell cycle arrest upon DNA damage
Regulation of cell-cycle checkpoints is an integral part of the DDR (1, 9, 31, 32). Irradiationinduced checkpoints are activated during the G1 to S transition, the S phase, and the G2/M cell cycle boundary. To determine whether the loss of RAP80 affected cell cycle checkpoints, we 
of cells in G2/M, consistent with a G2/M arrest (Fig. 4D) . At 48 h after IR, the percentage of WT MEFs in G2/M decreased, whereas that of RAP80 -/-MEFs remained elevated. The prolonged G2/M arrest could be explained by the hypothesis that repair of DNA damage is less efficient in RAP80 -/-MEFs.
RAP80 suppresses spontaneous and IR-induced genomic instability
Premature senescence observed in MEFs deficient in H2AX, ATM or BRCA1 expression has been reported to be associated with chromosomal instability (1, 3, 28, 33) . Phosphorylation of H2AX (ȖH2AX) is thought to be a reliable indicator for DNA damage and genomic instability (2, 34) . To examine the effect of the loss of RAP80 on genomic stability, we compared the number positive nuclei than WT MEFs (Fig. 5A ). All RAP80 -/-and WT MEFs were γ-H2AX positive upon 4 Gy IR exposure (Fig. 5A, B) ; however, the γ-H2AX foci persisted longer in RAP80
-/-MEFs than in WT MEFs (Fig. 5C ). In addition, at 24 hours after IR RAP80 -/-MEFs exhibited a greater extent of nuclear fragmentation as well as more micronuclei compared to WT MEFs (Fig.   5D ). These observations are consistent with our conclusion that genetic lesions are repaired less efficiently in RAP80 -/-MEFs than in WT.
To further examine whether the loss of RAP80 expression resulted in genomic instability, we analyzed metaphase spreads prepared from RAP80 -/-and WT iMEFs treated with 4 Gy IR. An increase in the number of sister chromatid exchanges was observed in RAP80 -/-MEFs (Fig. S4A,   B ) consistent with studies examining the effect of RAP80 knockdown by siRNA on genome stability (21, 30) .
RAP80 -/-mice exhibit an increased risk for spontaneous and IR-induced lymphomas
Mice deficient in several DDR proteins have been reported to exhibit an increased susceptibility to cancer development due to increased genomic instability (2, 35, 36) . Because the loss of RAP80 expression results in less efficient DNA damage repair and enhanced genome instability, it has been suggested that it might influence cancer risk as well. We therefore monitored WT and RAP80 -/-mice for over 20 months for spontaneous tumor formation. During the first 10 months, none of the WT or RAP80 -/-mice developed tumors. However, by 20 months, 52% of the RAP80 -/-mice had developed either thymic or splenic lymphomas, whereas only 1 out of 28 WT mice (3.6%) developed lymphoma (Fig. 6A) . Occasionally, these lymphomas were found to infiltrate various non-lymphoid organs, including liver, lung, and kidney ( Fig. S5A-F ).
In addition, RAP80 -/-mice were more susceptible to IR-induced lymphoma formation. After exposure to 6 Gy IR, about 18% (4/22) of the RAP80 -/-mice developed thymic lymphomas over a 6-month period, whereas only 4.7% (1/21) of the WT littermate controls did (Fig. 6B) .
Loss of RAP80 accelerates tumor formation in p53 -/-and p53 +/-mice
Previous studies have shown that the loss of the tumor suppressor p53 greatly enhances tumor development in mice (35, 37) . To determine whether the additional loss of RAP80 might further enhance tumor development in p53 -/-mice, we examined tumor development in RAP80
-/-p53 -/-mice did not show any developmental defects, but exhibited a significant decrease in tumor-free survival compared to p53 -/-controls (Fig. 6A ).
p53 +/-mice have been reported to develop lymphomas and sarcomas at the age of 6-9 months and are widely used in short-term carcinogenicity testing (35, 37 (Fig. 6C) . In addition, the average tumor weight of thymic lymphomas in p53 +/-RAP80 -/-mice was significantly greater than that of p53 +/-mice (Fig. 6D) . These results further support our conclusion that RAP80 deficiency enhances lymphoma development.
RAP80 -/-mice exhibit an increased susceptibility to DMBA-induced mammary gland tumor development
We next compared the susceptibility of RAP80 -/-and WT mice to DMBA-induced tumor formation. DMBA has been reported to induce the development of mammary gland and ovarian carcinomas, as well as lymphomas (22, 38) . In our study, female WT and RAP80 -/-mice were treated with DMBA once per week for 4 weeks and the development of mammary gland tumor formation was monitored by weekly palpation for a period of 10 months. Over a period of 10 months only 5% of the WT mice developed DMBA-induced mammary gland tumors, which is consistent with reports that the C57BL6 strain is generally resistant to the development of DMBA-induced mammary tumors. In contrast, 40% of RAP80 -/-mice developed mammary gland tumors (Fig. 7A ). These observations support our hypothesis that the loss of RAP80 function causes an increased risk of mammary cancer development. DMBA treatment also induced lymphomas and ovarian carcinomas in both WT and RAP80 -/-mice; however, no statistically significant difference in frequency was observed between WT and RAP80 -/-mice.
The overall tumor-free survival remained significantly different between RAP80 -/-and WT mice (Fig. 7B) . Collectively, these observations indicate that a deficiency in RAP80 increases the 
an increase in CtIP and BACH1 foci has been reported in U2OS cells in which RAP80 is downregulated (21, 30, 40) . These observations would be consistent with more extensive end processing of spontaneous single and double strand breaks in RAP80-deficient cells and with the concept that loss of RAP80 function leads to deficient DSB repair and increased chromosome instability.
A major role of DDR proteins in mammalian cells is to maintain genomic integrity.
Impairment of the DDR process results in genome instability and increased cancer risk. In this study, we examined whether the loss of RAP80 expression affected cancer risk in several different murine cancer models. Our data showed that by 20 months the percentage of spontaneously developing lymphomas in RAP80 -/-mice was significantly greater than in WT mice (52% versus 3.6%, respectively). IR exposure accelerated lymphoma formation in both WT and RAP80 -/-mice; however, RAP80 -/-mice remained more susceptible. Similar findings were recently reported by Wu et al. (41) . These observations indicate that loss of RAP80 enhances the susceptibility to lymphoma development consistent with the hypothesis that RAP80 functions as tumor suppressor.
It is well established that p53 acts as a tumor suppressor and plays an important role in determining heritable cancer risk (31, 35, 42) . Inactivation of p53 acts cooperatively with genetic alterations in other tumor suppressor or oncogenes to increase cancer risk (43) . In this study, we
showed that RAP80 -/-p53 -/-mice, which is likely due to the very small latency in tumor development.
Heterozygous p53 knockout mice also exhibit a predisposition for developing lymphoma, sarcoma, and carcinoma and exposure to IR considerably reduces the latency to tumor formation and survival (37) . We showed that p53 +/-RAP80 -/-mice were significantly more susceptible to the development of IR-induced thymic lymphomas than p53 +/-mice (78.5% versus 42.8%, respectively). These observations suggest that inactivating RAP80 and p53 mutations cooperate in promoting tumorigenesis. The latter is consistent with the concept that RAP80 functions as a tumor suppressor. In agreement with previous observations (18), we found that the ability of several p53 activators to induce cell death and the expression of p53 target genes was significantly enhanced in RAP80 -/-MEFs. As proposed for its modulation of BRCA1 (30), RAP80 might suppress the ability of p53 to transactivate apoptotic target genes in the presence of DNA stress and damage signals thereby increasing the time to repair.
In humans, germline mutations in BRCA1 and BRCA2 account for 5-7% of familial breast cancers (10, 44) . Because RAP80 is part of a BRCA1 complex, we were particularly interested in determining whether RAP80 -/-mice were more susceptible to DMBA-induced mammary cancer development. We found that RAP80 -/-mice were significantly more susceptible to DMBAinduced mammary cancer development than WT mice. In addition to mammary cancer, DMBA treatment also enhanced the formation of lymphomas and ovarian cancer. Our results show that total tumor-free survival was significantly reduced in RAP80 -/-mice. These observations are consistent with our conclusion that loss of RAP80 enhances cancer risk. Several recent studies investigating an association between RAP80 mutations and breast cancer risk in humans reported that truncating mutations of the RAP80 gene are not associated with familial breast cancer, while RAP80 haplotype or rare missense mutations may be weakly or moderately associated with elevated risk of breast cancer (45) (46) (47) . A separate study found an association between a RAP80
Research. haplotype and elevated ovarian cancer risk (5) . Screening of Finnish BRCA1/BRCA2 mutationnegative breast cancer families revealed the presence of several RAP80 variants (21) ; however, whether these are associated with increased cancer risk remains to be established. Overall these studies appear to indicate that the mutations identified within RAP80 to-date do not play a major role in increasing the risk of breast cancer. In summary, our study indicates that the loss of RAP80 enhances genome instability and increases the susceptibility to cancer development in several mouse models of human cancer. The impact of RAP80 on DNA repair and maintenance of genomic stability are consistent with the concept that RAP80 can function as a tumor suppressor. 
Legends
